🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
MBX Biosciences, Inc. (MBX)
NASDAQ: MBX · Real-Time Price · USD
51.09
-2.32 (-4.34%)
Nov 20, 2026, 12:43 PM EST - Market open

MBX Biosciences Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22
Net Income
-145.1-86.97-61.92-32.56-26.14
Depreciation & Amortization
0.640.350.240.160.06
Loss (Gain) From Sale of Assets
---0.07-
Loss (Gain) From Sale of Investments
-1.76-3.61-2.93-1.04-0.03
Stock-Based Compensation
41.758.685.222.040.31
Other Operating Activities
0.040.030.110.11.39
Change in Accounts Payable
3.05-2.463.930.410.67
Change in Other Net Operating Assets
5.374.030.67-1.150.62
Operating Cash Flow
-96.01-79.95-54.68-31.98-23.12
Operating Cash Flow Growth
-----

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22
Capital Expenditures
-3.32-1.93-0.87-0.13-0.44
Investment in Securities
-151.71-81.78-159.72-30.8-10.97
Investing Cash Flow
-155.03-83.71-160.6-30.93-11.41

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22
Short-Term Debt Issued
----10
Total Debt Issued
----10
Net Debt Issued (Repaid)
----10
Issuance of Common Stock
190.86190.36174.950.740.03
Other Financing Activities
-1.05-0.77-4.34-0.03-0.46
Financing Cash Flow
189.81189.59234.169.2246.06

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22
Net Cash Flow
-61.2325.9418.836.3111.53

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22
Free Cash Flow
-99.33-81.88-55.56-32.11-23.56
Free Cash Flow Growth
-----
Free Cash Flow Per Share
-2.12-2.24-5.22-31.52-35.33
Levered Free Cash Flow
-54-52.44-33.27-20.56-
Unlevered Free Cash Flow
-54-52.44-33.27-20.56-

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22
Change in Working Capital
8.421.584.6-0.741.29
SEC Filings: 10-K · 10-Q